Revenue
2015
2016
2017
2018
2019
2020
2022
2023
2024
Odyssey Health, Inc. (ODYY)
Price$0.0157Cached quote
Net income
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2015
2016
2017
2022
2023
2024
Total cash / debt
CashTotal debt
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0 | $0 | $0 | — | $0 | $0 | $0 | $0 | $37,452 | $257,220 |
| Gross profit | — | — | — | — | — | $0 | $0 | $0 | $0 | $17,153 | $28,730 |
| Gross margin | — | — | — | — | — | — | — | — | — | 45.80% | 11.17% |
| Research & development | $0 | $0 | $170,000 | $1.3M | $1.6M | $20,237 | $23.0M | — | — | — | — |
| Operating expenses | — | $2.1M | $5.1M | $8.1M | — | $3.8M | $23.6M | $420,442 | $167,575 | $90,721 | $184,628 |
| Operating income | −$1.0M | −$2.1M | −$5.3M | −$8.1M | −$15.9M | −$3.8M | −$23.6M | −$420,442 | −$167,575 | −$73,568 | −$155,898 |
| Operating margin | — | — | — | — | — | — | — | — | — | −196.43% | −60.61% |
| EBITDA | — | −$2.1M | −$5.3M | −$8.1M | −$15.9M | −$3.8M | −$23.6M | −$409,891 | −$157,023 | −$68,430 | −$155,898 |
| EBITDA margin | — | — | — | — | — | — | — | — | — | −182.71% | −60.61% |
| Net income | −$1.7M | −$842,316 | −$5.9M | −$8.4M | −$16.9M | −$4.3M | −$23.4M | −$483,115 | −$197,844 | −$86,117 | −$160,698 |
| Net profit margin | — | — | — | — | — | — | — | — | — | −229.94% | −62.47% |
| Basic EPSper basic share | -$0.02 | -$0.01 | -$0.07 | -$0.09 | -$0.18 | -$0.05 | -$0.34 | $0.00 | $0.00 | $0.00 | $0.00 |
| Diluted EPSper diluted share | -$0.02 | -$0.01 | -$0.07 | -$0.09 | -$0.18 | — | — | — | — | — | — |
Owners
Reported shareholders